Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Temporal variations in serum metabolites of bipolar disorder around the summer solstice: A targeted metabolomics
Xue Li1, Xinzi Liu1, Ziyan Li1
1Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders; National Clinical Research Center for Mental Disorders; National Center for Mental Disorders; Beijing Anding Hospital, Capital Medical University, Beijing, China.
Abstract:
Bipolar disorder (BD) is a severe mood disorder characterized by seasonal variations, but the underlying metabolite changes are not well understood. This study employed targeted metabolomics to examine serum metabolite changes in 9 BD patients and 9 healthy controls (HCs) at 6 time points: 15 d before, on, and 15 d after the spring equinox and summer solstice. In the summer, 4 metabolites in HCs and 25 in BD showed time effects, with phenylalanine (Phe) -alanine-betaine showing interaction effects; however, none were significant after false discovery rate (FDR) correction. Analysis across the spring and summer revealed significant time effects in 48 metabolites in HCs and 201 in BD, with Phe showing notable interactions. In the spring, Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale scores, retardation, sleep disturbance, and psychic anxiety factors correlated positively with Homoarginine (HArg), Phe, and lactate. In the summer, Young Mania Rating Scale (YMRS) was positively associated with 3-hydroxyphenylacetic acid and negatively with Harg, glutamine, and citrate; sleep disturbance was positively linked to sarcosine, and retardation factor negatively linked to HArg. These seasonal changes in BD metabolites were primarily linked to the biosynthetic pathways of phenylalanine, tyrosine, and tryptophan. Further research is needed to understand how these metabolic shifts influence BD episodes.
More Related Videos
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
Related Concept Videos
Bipolar Disorder
Mania and Antimanic Drugs: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...